Analysis of the epidemiological profile, treatment, and length of hospital stay of patients admitted with heart failure in a public hospital in the Federal District
DOI:
https://doi.org/10.51723/hrj.v7i35.1230Keywords:
Heart failure, Hospitalization, Mortality, Medication adherence, ComorbidityAbstract
Objectives: To analyze the clinical and epidemiological profile, instituted treatments, and clinical outcomes of patients hospitalized with decompensated HF in a public hospital in the Federal District, emphasizing factors associated with disease severity and length of stay. Methods: This was an observational, cross-sectional, and analytical study conducted between January 2024 and January 2025, including 115 patients admitted to the ward, red room, or emergency unit of the Regional Hospital of Sobradinho (HRS-DF). Adults aged ≥18 years with a principal diagnosis of decompensated HF (ICD-10 I50/I50.9) were included. Exclusion criteria were stable secondary HF, hospital stays <24 hours, heart transplantation, or exclusive palliative care. Data were obtained from electronic medical records and analyzed using descriptive and inferential statistics (chi-square and Fisher tests) with Jamovi, RStudio, and Excel software. Results: Most patients were male (53.9%), with a mean age of 69.4 years and left ventricular ejection fraction <40% in 49.6%. The most prevalent comorbidities were hypertension (81.7%), diabetes (35.7%), and anemia (34.8%). In-hospital mortality was 16.5%. Therapeutic adherence was associated with better outcomes (p=0.038), while valvular etiology correlated with higher mortality (p=0.035). Advanced support use was strongly associated with death (p<0.001). Conclusion: The clinical profile of HF patients within the SUS reveals major care gaps, highlighting low adherence, underuse of evidence-based therapies, and delayed diagnosis. Integrated management strategies are essential to improve outcomes and reduce the burden of HF in the public health system.
References
Sociedade Brasileira de Cardiologia. Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda. ArqBrasCardiol. 2018;111(3):436-539. doi: 10.5935/abc.20180190.
Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8(1):30-41. doi:10.1038/nrcardio.2010.165.
Heidenreich PA, Bozkurt B, Aguilar D et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure. Circulation. 2022;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063.
McDonagh TA, Metra M, Adamo M et al. 2023 ESC guidelines for the diagnosis and treatment of heart failure. Eur Heart J. 2023;44(40):3627-726. doi: 10.1093/eurheartj/ehad195.
Ponikowski P, Voors AA, Anker SD et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37(27):2129-200. doi: 10.1093/eurheartj/ehw128.
Montera MW, Mesquita ET, Colafranceschi AS et al. Atualização da Diretriz Brasileira de Insuficiência Cardíaca – 2021. ArqBrasCardiol. 2021;116(6):1174-262. doi: 10.36660/abc.20210171.
Abraham WT, Adams KF, Fonarow GC et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the ADHERE Registry. J Am Coll Cardiol. 2005;46(1):57-64. doi: 10.1016/j.jacc.2005.03.051.
Lala A, McNulty SE, Mentz RJ et al. Acute heart failure: epidemiology, risk factors, and outcomes. JACC Heart Fail. 2020;8(12):999-1012. doi: 10.1016/j.jchf.2020.09.005.
Pang PS, Collins SP, Miro O et al. Clinical course and outcomes of acute heart failure. Circulation. 2021;141(7):550-65. doi: 10.1161/CIRCULATIONAHA.120.047568.
DATASUS. Departamento de Informática do Sistema Único de Saúde – SIH/SUS. Brasília: Ministério da Saúde; 2024. Disponível em: http://tabnet.datasus.gov.br Acesso em: 26 ago. 2025.
Nuñez J, Lupón J, Núñez E et al. Quantificación y tratamiento de la congestión en insuficiencia cardíaca: una visión clínica y fisiopatológica. Nefrología. 2022;42(2):145-62. doi: 10.1016/j.nefro.2021.11.003.
Montera MW, Almeida DR, Tinoco EM et al. BREATHE Registry: baseline characteristics and hospital outcomes in patients with acute decompensated heart failure in Brazil. ArqBrasCardiol. 2013;100(5):401-8. doi: 10.5935/abc.20130064.
Piano MR, Phillips SA. Alcoholic cardiomyopathy: pathophysiologic insights. CardiovascToxicol. 2017;17(3):218-33. doi: 10.1007/s12012-016-9364-7.
Burnier M, Egan BM. Adherence in hypertension. Circ Res. 2019;124(7):1124-40. doi: 10.1161/ CIRCRESAHA.118.313220.
Greene SJ, Butler J, Albert NM et al. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry. J Am Coll Cardiol. 2018;72(4):351-66. doi: 10.1016/j.jacc.2018.04.070.
Wu JR, Moser DK, Lennie TA, Burkhart PV. Medication adherence in patients who have heart failure: a review of the literature. Nurs Clin North Am. 2008;43(1):133-53. doi: 10.1016/j.cnur.2007.10.006.
Samet JH, Larson MJ, Horton NJ, Doyle K, Winter M, Saitz R. Alcohol consumption, health risks, and medication adherence. Alcohol Res Health. 2004;28(2):144-51.
McMurray JJ, Packer M, Desai AS et al. Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993-1004. doi: 10.1056/NEJMoa1409077.
Yancy CW, Jessup M, Bozkurt B et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure. J Am Coll Cardiol. 2017;70(6):776-803. doi: 10.1016/j.jacc.2017.04.025.
Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341(10):709-17. doi: 10.1056/NEJM199909023411001.
Nieuwlaat R, Wilczynski N, Navarro T et al. Interventions for enhancing medication adherence. Cochrane DatabaseSyst Rev. 2014;11:CD000011. doi: 10.1002/14651858.CD000011.pub4.
McMurray JJ, Solomon SD, Inzucchi SE et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381(21):1995-2008. doi: 10.1056/NEJMoa1911303.
Hackett ML, Köhler S, O’Brien JT, Mead GE. Barriers to medication adherence in stroke patients: a systematic review. Int J Stroke. 2014;5(3):137-42. doi: 10.1111/j.1747-4949.2010.00427.x.
DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200-9. doi: 10.1097/01.mlr.0000114908.90348.f9.
Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336(8):525-33. doi: 10.1056/NEJM199702203360801.
Damman K, Valente MA, Voors AA, O’Connor CM, van Veldhuisen DJ, Hillege HL. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail. 2014;20(2):103-10. doi:10.1016/j.cardfail.2013.10.005.
Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527-39. Available from: https://doi.org/10.1016/j.jacc.2008.07.051
Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2014;35(38):2468-76. doi: 10.1093/eurheartj/ehu191.
Okonko DO, Grzeslo A, Witkowski T et al. Anemia and iron deficiency in heart failure: prognostic impact and therapeutic considerations. J Am Coll Cardiol. 2008;52(2):105-16. doi: 10.1016/j.jacc.2008.03.061.
Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263-71. doi: 10.1016/j.jacc.2013.02.092.
Alonso A, Lopez FL, Matsushita K, Loehr LR, Agarwal SK, Chen LY et al. Tobacco smoking and the risk of heart failure. Circ Heart Fail. 2017;10(3):e003188. doi:10.1161/CIRCHEARTFAILURE.116.003188.
Santos A, Souza GC, Gomes RC et al. Tempo de internação e prognóstico em pacientes com insuficiência cardíaca aguda. Rev SocCardiol Estado de São Paulo. 2020;30(3):123-30.
Wadhwani L, Balasubramanian K, Joseph J et al. Contemporary use of sacubitril/valsartan in heart failure. J Clin Med. 2023;12(5):1956. doi: 10.3390/jcm12051956.
Roger VL. Epidemiology of heart failure: a contemporary perspective. Circ Res. 2021;128(10):1421-34. doi: 10.1161/CIRCRESAHA.121.318172.
Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7-11. doi: 10.15420/cfr.2016:25:2.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Nathalia Ingrid Mendes da Silva Rodrigues, Renato de Carvalho Barros, Leonardo Sousa Cointo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Esta licença permite que outros distribuam, remixem, adaptem e desenvolvam seu trabalho, mesmo comercialmente, desde que atribuam crédito à revista pela criação original.
